ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2022

Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M).

S R Aravind et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.